Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetics and Genomics Program, |
RCV001293086 | SCV001434069 | likely benign | Primary dilated cardiomyopathy | criteria provided, single submitter | research | ||
Invitae | RCV002069367 | SCV002491708 | likely benign | Duchenne muscular dystrophy | 2023-12-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002430061 | SCV002682000 | uncertain significance | Cardiovascular phenotype | 2021-05-09 | criteria provided, single submitter | clinical testing | The p.V3410I variant (also known as c.10228G>A), located in coding exon 71 of the DMD gene, results from a G to A substitution at nucleotide position 10228. The valine at codon 3410 is replaced by isoleucine, an amino acid with highly similar properties. This variant has been detected in a suspected Duchenne or Becker muscular dystrophy cohort; however, details were limited (Kumar SH et al. PLoS One, 2020 Jun;15:e0232654). Based on data from gnomAD, the A allele has an overall frequency of 0.006% (10/177649) total alleles studied, with 3 hemizygotes observed. The highest observed frequency was 0.02% (3/17753) of South Asian alleles. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |